Clinical Trials in Ovarian Cancer

by Christine S. Walsh
Rutgers University Press, 2017
eISBN: 978-0-8135-9265-7, Paper: 978-0-8135-8647-2

When a patient is diagnosed with a gynecological malignancy, she and her doctors must make urgent, high-risk decisions about her course of treatment. In selecting an appropriate plan of care, physicians must weigh the patient’s individual needs, the tumor’s specific characteristics, and the treatment’s potential side effects. Because there is no one-size-fits-all treatment solution, a plethora of clinical trials have been performed on ovarian cancer patients, but clinicians may struggle to keep up with this ever-growing body of research.   


Collecting and synthesizing research findings from a wide array of medical journal articles and book chapters, Clinical Trials in Ovarian Cancer provides physicians with an invaluable resource. Gynecologic oncologist Christine S. Walsh systematically outlines each of the seminal Phase III trials that have shaped the treatment of ovarian cancers, detailing the rationale for the trial, the patient population studied, treatment delivery methods, efficacy, toxicity, and trial conclusions. She provides a clear overview of established treatments, as well as still-controversial experimental approaches. 


The first book to organize this cutting-edge research into an easy-to-use reference, Clinical Trials in Ovarian Cancer should help medical personnel at all levels provide their patients with the highest standard of care. 


CHRISTINE S. WALSH is an associate professor and attending physician at Cedars-Sinai hospital in Los Angeles, California. She is also associate professor at the Geffen School of Medicine at UCLA. She serves as director for the gynecologic oncology fellowship program. 

Browser-based reading powered by
Electronic file fulfilled by BiblioVault.